NO20092078L - Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet - Google Patents
Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighetInfo
- Publication number
- NO20092078L NO20092078L NO20092078A NO20092078A NO20092078L NO 20092078 L NO20092078 L NO 20092078L NO 20092078 A NO20092078 A NO 20092078A NO 20092078 A NO20092078 A NO 20092078A NO 20092078 L NO20092078 L NO 20092078L
- Authority
- NO
- Norway
- Prior art keywords
- addiction
- treatment
- procedure
- alcohol abuse
- abuse
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86137506P | 2006-11-28 | 2006-11-28 | |
PCT/US2007/084751 WO2008067177A2 (en) | 2006-11-28 | 2007-11-15 | Methods for the treatment of alcohol abuse, addiction and dependency |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20092078L true NO20092078L (no) | 2009-08-24 |
Family
ID=39345316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20092078A NO20092078L (no) | 2006-11-28 | 2009-05-28 | Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080200492A1 (ja) |
EP (1) | EP2101769B1 (ja) |
JP (1) | JP2010511055A (ja) |
KR (1) | KR20090087042A (ja) |
CN (1) | CN101616669B (ja) |
AU (1) | AU2007325365A1 (ja) |
CA (1) | CA2672273C (ja) |
CO (1) | CO6190520A2 (ja) |
EA (1) | EA200970518A1 (ja) |
GT (1) | GT200900139A (ja) |
IL (1) | IL198792A0 (ja) |
MX (1) | MX2009005640A (ja) |
NO (1) | NO20092078L (ja) |
WO (1) | WO2008067177A2 (ja) |
ZA (1) | ZA200904455B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1601674B1 (en) * | 2002-09-09 | 2012-08-08 | Janssen Pharmaceutica NV | Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
MX2009005641A (es) | 2006-11-28 | 2009-06-05 | Janssen Pharmaceutica Nv | Sales de 3-(3-amino-2-(r)-hidroxi-propil)-1-(4-fluoro-fenil)-8-(8- metil-naftalen-1-ilmetil)-1,3,8-triaza-espiro[4,5]deca n-4-ona. |
EP2150552B1 (en) * | 2007-04-09 | 2013-01-02 | Janssen Pharmaceutica NV | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
CN104621437A (zh) * | 2015-01-21 | 2015-05-20 | 胡家宁 | 一种用于抵抗酒精依赖的食品 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486362A (en) * | 1991-05-07 | 1996-01-23 | Dynagen, Inc. | Controlled, sustained release delivery system for treating drug dependency |
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
DE60122903T2 (de) | 2000-08-07 | 2006-12-21 | Eastman Chemical Co., Kingsport | Thermisch stabile anthrachinonfarbstoffe mit copolymerisierbaren vinylgruppen |
EP1601674B1 (en) * | 2002-09-09 | 2012-08-08 | Janssen Pharmaceutica NV | Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
-
2007
- 2007-11-15 WO PCT/US2007/084751 patent/WO2008067177A2/en active Application Filing
- 2007-11-15 EP EP07868760A patent/EP2101769B1/en active Active
- 2007-11-15 CN CN2007800505470A patent/CN101616669B/zh not_active Expired - Fee Related
- 2007-11-15 EA EA200970518A patent/EA200970518A1/ru unknown
- 2007-11-15 MX MX2009005640A patent/MX2009005640A/es active IP Right Grant
- 2007-11-15 US US11/940,397 patent/US20080200492A1/en not_active Abandoned
- 2007-11-15 AU AU2007325365A patent/AU2007325365A1/en not_active Abandoned
- 2007-11-15 CA CA2672273A patent/CA2672273C/en not_active Expired - Fee Related
- 2007-11-15 KR KR1020097011658A patent/KR20090087042A/ko not_active Application Discontinuation
- 2007-11-15 JP JP2009539406A patent/JP2010511055A/ja not_active Withdrawn
-
2009
- 2009-05-17 IL IL198792A patent/IL198792A0/en unknown
- 2009-05-25 GT GT200900139A patent/GT200900139A/es unknown
- 2009-05-28 NO NO20092078A patent/NO20092078L/no not_active Application Discontinuation
- 2009-05-29 CO CO09055461A patent/CO6190520A2/es not_active Application Discontinuation
- 2009-06-26 ZA ZA200904455A patent/ZA200904455B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200904455B (en) | 2010-09-29 |
CA2672273A1 (en) | 2008-06-05 |
GT200900139A (es) | 2010-04-29 |
EP2101769A2 (en) | 2009-09-23 |
JP2010511055A (ja) | 2010-04-08 |
US20080200492A1 (en) | 2008-08-21 |
CN101616669B (zh) | 2013-05-29 |
IL198792A0 (en) | 2010-02-17 |
WO2008067177A2 (en) | 2008-06-05 |
EA200970518A1 (ru) | 2009-12-30 |
CN101616669A (zh) | 2009-12-30 |
CO6190520A2 (es) | 2010-08-19 |
AU2007325365A1 (en) | 2008-06-05 |
EP2101769B1 (en) | 2012-10-24 |
WO2008067177A3 (en) | 2008-10-30 |
CA2672273C (en) | 2016-01-12 |
KR20090087042A (ko) | 2009-08-14 |
MX2009005640A (es) | 2009-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120961T1 (el) | Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος | |
MY160041A (en) | Compositions and methods for treating parasitic infections | |
EP1835929B8 (en) | Anti-kir combination treatments and methods | |
SG160436A1 (en) | Polymer interlayers comprising skin layers | |
NO20063987L (no) | Anti-cancerterapier | |
MX2009002496A (es) | Combinaciones que contienen un derivado de 4-acilaminopiridina. | |
BRPI0819819A2 (pt) | Preparações, método e kits ùteis para o tratamento de tosse | |
PL2018441T3 (pl) | Mikroorganizmy znakowane i sposoby znakowania | |
ATE551077T1 (de) | Minderung einer infektion in zusammenhang mit einer medizinischen vorrichtung | |
DK3253171T3 (da) | Fremgangsmåder og apparater til random access i et ortogonalt kommunikationssystem med multiple access | |
WO2009086471A3 (en) | Synergistic antiparasitic compositions and screening methods | |
IL186447A0 (en) | Methods for the treatment of substance abuse and dependence | |
BRPI0911482A2 (pt) | Uso de epotilona d no tratamento de doenças associadas a tau incluindo doenças de alzheimer | |
NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
GB0808663D0 (en) | System and method for the secure, transparent and continuous synchronization of access credentials in an arbitrary third party system | |
EP2002012A4 (en) | METHOD FOR THE TREATMENT, REDUCTION AND INHIBITION OF AGE SKIN IN THE SKIN | |
EP1759582A4 (en) | PRESERVATIVE SOLUTION FOR CELLS, TISSUE AND ORGANS CONTAINING RARE SUGAR, AND CONSERVATION PROCESSES USING THIS SOLUTION | |
WO2007137224A3 (en) | Method of treatment | |
NO20072890L (no) | Behandling av mastitt | |
NO20092078L (no) | Fremgangsmate for behandling av alkoholmisbruk, adiksjon og avhengighet | |
MX2009003022A (es) | Composiciones y metodos para tratar picaduras de medusa. | |
WO2007067795A3 (en) | Methods for identifying and targeting tumor stem cells based on nuclear morphology | |
WO2009023846A3 (en) | Methods for heat shock protein dependent cancer treatment | |
WO2008115478A3 (en) | Method of cancer detection and treatment | |
MX2009004142A (es) | Metodo para prevenir o tratar sindrome metabolico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |